Urinary tract and genital infections with dapagliflozin and empagliflozin across type 2 diabetes, heart failure, and chronic kidney disease: An indication- and sex-stratified disproportionality analysis of eudravigilance reports

Biomedicine & Pharmacotherapy · Elsevier

Аннотация

Publication date: November 2026 Source: Biomedicine & Pharmacotherapy, Volume 204 Author(s): Agnese Graziosi, Maria Antonietta Riemma, Danila Gurgone, Alice Schianchi, Fabiana Morroni, Giulia Sita, Francesco Baratta, Chiara Veronese, Daniele Pastori, Gianluca Gazzaniga, Elena Mele, Fabrizio Oliva, Arianna Pani

Читать у издателя →

Похожие статьи